SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.20    2.40 (1.57%)
Bid:
155.00
Ask:
155.40
Spread: 0.40 (0.258%)
Market Cap: £888.23m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading Statement

27 Oct 2017 07:00

ELEMENTIS PLC - Trading Statement

ELEMENTIS PLC - Trading Statement

PR Newswire

London, October 26

Elementis plc

Q3 Trading Update

Sustained good revenue performance and overall trading on track

Elementis plc (“Elementis” or the “Group”), a Global Specialty Chemicals Company, today issues its planned period end trading update for the three months ended 30 September 2017.

In the third quarter the Group has performed in line with expectations and seen a continuation of the trends experienced across the first half of the year.

Specialty Products performed well and in line with expectations

Coatings saw a good sales performance across all regions versus last year, however higher raw material costs impacted profit growth.

Personal Care continued to benefit from increased penetration of our hectorite based products across categories and geographies. The integration of SummitReheis remains on track with synergies well underpinned, and we continue to implement pricing responses to recover raw material cost inflation. We are creating a Personal Care business of scale.

Energy has remained strong, reflecting higher activity levels and market share gains. Momentum in the business remains extremely positive.

Chromium on track to deliver full year improvement

Chromium has continued to perform well and in line with the trends experienced across the first half of the year. Despite unplanned production outages at our Castle Hayne and Corpus Christi facilities during the third quarter we continue to expect an improved full year outcome versus 2016.

Surfactants disposal progressing well

As previously indicated, the favourable first half conditions in Surfactants have not continued. The sale process for the business is progressing well and we continue to expect resolution in early 2018.

Commenting on the performance, CEO, Paul Waterman said,

“Elementis has delivered another good revenue performance in the third quarter and overall trading is on track. Trends remain similar to those reported in the first half of the year and we remain on course to grow operating profit across all three segments in 2017. Going forward, we continue to see significant potential for Elementis as we implement our Reignite Growth strategy”.

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

Martin Robinson, Tulchan Tel: 020 7353 4200

Date   Source Headline
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPreliminary results year ended 31 December 2021
1st Mar 20222:03 pmRNSDirector Declaration
1st Mar 202211:18 amRNSBlock listing Interim Review
18th Jan 20227:00 amRNSTrading Update
10th Jan 20221:20 pmRNSHolding(s) in Company
4th Jan 202211:48 amRNSTotal Voting Rights
1st Dec 202111:10 amRNSTotal Voting Rights
10th Nov 202112:20 pmRNSHolding(s) in Company
3rd Nov 202111:25 amRNSHolding(s) in Company
1st Nov 20211:44 pmRNSTotal Voting Rights
28th Oct 20217:00 amRNSQ3 Trading Update
19th Oct 20216:10 pmRNSDirector Declaration
5th Oct 20218:42 amRNSDirector Declaration
1st Sep 20219:49 amRNSBlock listing Interim Review
2nd Aug 202110:22 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSHalf-year Report
5th Jul 202110:15 amRNSTotal Voting Rights
25th Jun 20212:59 pmRNSHolding(s) in Company
23rd Jun 20212:56 pmRNSDirector Declaration
1st Jun 202110:06 amRNSTotal Voting Rights
13th May 20213:39 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Statement
22nd Apr 20213:26 pmRNSAdditional Listing
20th Apr 20214:18 pmRNSResponse to Innospec Inc. announcement
20th Apr 20212:36 pmRNSPress Speculation Re Possible Offer for Elementis
9th Apr 20215:15 pmRNSAnnual Financial Report
7th Apr 20215:31 pmRNSDirector/PDMR Shareholding
1st Apr 20218:49 amRNSDirector/PDMR Shareholding
30th Mar 20214:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.